Use our interactive assessment to get a personalized readiness score. See how your Model-Informed Drug Development (MIDD) strategy aligns with the latest ICH M15 guidance, FDA expectations, and EMA requirements.
ICH M15 Interactive Scorecard
Are you ready for the ICH M15 guideline?
The Certara ICH M15 scorecard
About Certara
Certara is dedicated to transforming drug discovery and development for good. We harness the power of biosimulation, advanced analytics, and regulatory expertise to create a future where treatments reach patients faster and more efficiently.
From discovery to market access and commercial, we tailor solutions to meet our clients’ most pressing challenges. Through strategic leadership and advanced predictive technologies, Certara provides comprehensive solutions to optimize drug development processes, reduce risks, and improve outcomes. Our clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries.
© 2025 Certara. All Rights Reserved. | Privacy policy